Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary interventionResults from the REPLACE-2 trial
Open Access
- 27 October 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (9) , 1792-1800
- https://doi.org/10.1016/s0735-1097(04)01601-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: